Cas:77259-54-2 Dynorphin A (1-9) manufacturer & supplier

Chemical Name:Dynorphin A (1-9)

CAS.NO:77259-54-2

Synonyms:TYR-GLY-GLY-PHE-LEU-ARG-ARG-ILE-ARG;DYNORPHIN A,FRAGMENT 1-9;DYNORPHIN A PORCINE FRAGMENT 1-9;DYNORPHIN A (1-9),PORCINE;L-Tyr-Gly-Gly-L-Phe-L-Leu-L-Arg-L-Arg-L-Ile-L-Arg-OH;YGGFLRRIR;DYNORPHIN A (1-9);H-TYR-GLY-GLY-PHE-LEU-ARG-ARG-ILE-ARG-OH

Molecular Formula:C₅₂H₈₄N₁₈O₁₁

Molecular Weight:1137.34000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:1.41g/cm3

Index of Refraction:1.648

PSA:502.05000

Exact Mass:1136.66000

LogP:4.01280

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like TYR-GLY-GLY-PHE-LEU-ARG-ARG-ILE-ARG chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,H-TYR-GLY-GLY-PHE-LEU-ARG-ARG-ILE-ARG-OH physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,YGGFLRRIR Use and application,H-TYR-GLY-GLY-PHE-LEU-ARG-ARG-ILE-ARG-OH technical grade,usp/ep/jp grade.

Related News: Plexxikon filed a lawsuit against the pharma giant in 2017, alledging that Tafinlar, a rival to its melanoma drug Zelboraf that was brought to market in collaboration with Roche, has stepped on its intellectual property. The jury ruled in its favor, adding that the infringement is in fact willful. 9-methyl-3-(6-(thiophen-3-yl)pyridin-3-yl)-3,9-diazabicyclo[4.2.1]nonane fumarate manufacturers Sales for Tafinlar and Mekinist, the MEK inhibitor it was approved with, hit $672 million in 2016. Fast forward to 2020 and the duo generated $1.5 billion in revenue. 1,2,4-Triazin-5(4H)-one, 4-amino-6-cyclopentyl-3-(methylthio)- suppliers And finally, CHMP also concluded its investigation into bluebird bio’s Zynteglo, finding no evidence that it causes a blood cancer known as acute myeloid leukemia. (R)-2-Amino-2-carboxyethylmethanethiosulfonate vendor & factory “The Delta variant is clearly circulating, and it’s more contagious, and it seems to be causing more disease,” said ACIP member Katherine Poehling, M.D., an epidemiologist at Wake Forest School of Medicine. ,And finally, CHMP also concluded its investigation into bluebird bio’s Zynteglo, finding no evidence that it causes a blood cancer known as acute myeloid leukemia.